Cleared Traditional

K173310 - SmartTouch

K173310 is an FDA 510(k) clearance for SmartTouch, manufactured by Adherium (Nz), Ltd.. The device is a Class 2 Anesthesiology device with product code CAF cleared through the Traditional 510(k) pathway after a 159-day FDA review.

K173310 · Adherium (Nz), Ltd. · Anesthesiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 2018
Decision
159d
Days
Class 2
Risk

K173310 is an FDA 510(k) clearance for the SmartTouch. Classified as Nebulizer (direct Patient Interface) (product code CAF), Class II - Special Controls.

Submitted by Adherium (Nz), Ltd. (Auckland, NZ). The FDA issued a Cleared decision on March 26, 2018 after a review of 159 days - an extended review cycle.

This device falls under the Anesthesiology FDA review panel, regulated under 21 CFR 868.5630 - the FDA anesthesiology and respiratory device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Anesthesiology review framework, consistent with the majority of Class II 510(k) submissions.

View all Adherium (Nz), Ltd. devices

FDA 510(k) Submission Details - K173310

510(k) Number K173310 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 18, 2017
Decision Date March 26, 2018
Days to Decision 159 days
Submission Type Traditional
Review Panel Anesthesiology (AN)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
19d slower than avg
Panel avg: 140d · This submission: 159d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

CAF Device Classification - Class 2, Special Controls

Product Code CAF Nebulizer (direct Patient Interface)
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 868.5630
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Anesthesiology devices follow this clearance model.

Regulatory Peers - CAF Nebulizer (direct Patient Interface)

All 196
Devices cleared under the same product code (CAF) and FDA review panel - the closest regulatory comparables to K173310.
Smartinhaler
K180407 · Adherium (Nz), Ltd. · Jul 2018
HOMED Mesh Nebulizer
K170886 · Shenzhen Homed Medical Device Co., Ltd. · Jun 2018
MC 300R* Nebulizer
K173825 · Trudell Medical International · May 2018
MC 300* Nebulizer
K173367 · Trudell Medical International · Feb 2018
AirLife Misty Finity Nebulizer
K153748 · Care Fusion · May 2017
RTC 26-C Inline Aerosol Adapter
K162753 · Instrumentation Industries, Inc. · Feb 2017